Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹4.6 LAdmitted-Finance | ₹4.6 L | L1 | Admitted-Finance |
| 2 | L2₹7.1 L+₹2.5 L (53.5%)Admitted-Finance | ₹7.1 L+₹2.5 L (53.5%) | L2 | Admitted-Finance |
| 3 | L3₹10.5 L+₹5.9 L (128.2%)Admitted-Finance | ₹10.5 L+₹5.9 L (128.2%) | L3 | Admitted-Finance |
| 4 | L4₹25.7 L+₹21.1 L (458.3%)Admitted-Finance | ₹25.7 L+₹21.1 L (458.3%) | L4 | Admitted-Finance |
| 5 | L5₹43.4 L+₹38.8 L (843.5%)Admitted-Finance B 75 JHILMIL COLONY EAST DELHI DELHI 110095 | SHAHDARA | DELHI | 110095 | ₹43.4 L+₹38.8 L (843.5%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Kottakkal Surgicals L4 | RELIABLE PHARMA L6 | SOUTH END TRADE LINKS L3 | MEDI TRADE L5 | PREMIER PHARMA DISTRIBUTORS L7 | MEDI DARZEE HEALTHCARE L8 | MAAN PHARMACEUTICALS L2 | Supreme International Pharmaceuticals L1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj. 5-Fluorouracil 250mg/5ml | 20 | Nos | 10.5 ₹210 Lowest | 209 ₹4,180 | - | 213 ₹4,260 | 222 ₹4,440 | - | - | - |
| 2.00 | Inj.Bendamustine 100mg/ vial | 20 | Nos | 1,690.5 ₹33,810 | 825 ₹16,500 | 829.5 ₹16,590 | 799 ₹15,980 | 790 ₹15,800 | 1,012 ₹20,240 | 1,133 ₹22,660 | 609 ₹12,180 Lowest |
| 3.00 | Inj.Bortezomib 2mg | 100 | Nos | 1,058.4 ₹1,05,840 | 376 ₹37,600 Lowest | 513.45 ₹51,345 | 380 ₹38,000 | 399 ₹39,900 | 420 ₹42,000 | 786.5 ₹78,650 | 393.75 ₹39,375 |
| 4.00 | Tab. Capecitabine 500mg | 3,000 | Nos | 24.99 ₹74,970 | 48.55 ₹1,45,650 | 14.39 ₹43,170 | 51.11 ₹1,53,330 | 65 ₹1,95,000 | 319 ₹9,57,000 | 23.52 ₹70,560 | 13.65 ₹40,950 Lowest |
| 5.00 | Inj.Carboplatin 150mg | 60 | Nos | 1,424.85 ₹85,491 | 905 ₹54,300 | 1,190.83 ₹71,449.8 | 891 ₹53,460 Lowest | 999 ₹59,940 | - | 1,495.2 ₹89,712 | - |
| 6.00 | Inj.Cisplatin 1mg/mL | 40 | Nos | 113.93 ₹4,557.2 Lowest | 555 ₹22,200 | - | 425 ₹17,000 | 444 ₹17,760 | 540 ₹21,600 | 613.2 ₹24,528 | - |
| 7.00 | Inj.Cyclophosphamide 500mg | 200 | Nos | 65.52 ₹13,104 | 245 ₹49,000 | - | 248 ₹49,600 | 296 ₹59,200 | 26 ₹5,200 Lowest | - | - |
| 8.00 | Inj. Docetaxel 120mg | 50 | Nos | 2,205 ₹1,10,250 | 2,650 ₹1,32,500 | 554.4 ₹27,720 Lowest | 2,220 ₹1,11,000 | 2,215 ₹1,10,750 | 680 ₹34,000 | 826.35 ₹41,317.5 | 630 ₹31,500 |
| 9.00 | Inj.Doxorubicin 50mg | 200 | Nos | 300.3 ₹60,060 | 1,008 ₹2,01,600 | 239.4 ₹47,880 | 987 ₹1,97,400 | 985 ₹1,97,000 | 200 ₹40,000 Lowest | 235.2 ₹47,040 | - |
| 10.00 | Tab. Gefitinib 250mg | 2,000 | Nos | 30.03 ₹60,060 | 49.65 ₹99,300 | 15.54 ₹31,080 Lowest | 35.6 ₹71,200 | 34.55 ₹69,100 | 396 ₹7,92,000 | 23.52 ₹47,040 | 17.85 ₹35,700 |
Tender Value
Refer Docs
EMD Value
₹90,531
Closing Date
18 Aug 2026, 4:30 pmClosed
Director , DHS
Directorate of Health services, kavaratti
Procurement and Supply of Anticancer medicines required for Chemotherapy Unit of Indira Gandhi Hospital, Kavaratti, UT of Lakshadweep.
2026_UTL_3390_1
LD-09014/4/2026-Buf-HEALTH SERVICES
Open Tender
Medicines
Item Wise
LMS Kochi
Please refer Tender documents.
15 documents required · 15 mandatory
₹1,000
Yes
GM UTL
₹90,531
Yes
15 Sept 2026
29 Jul 2026
20 Aug 2026
29 Jul 2026
18 Aug 2026
29 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Inj. 5-Fluorouracil 250mg/5ml | 20 | Nos | 16 | ₹320 |
| 2 | Inj.Bendamustine 100mg/ vial | 20 | Nos | 890.4 | ₹17,808 |
| 3 | Inj.Bortezomib 2mg | 100 | Nos | 1,500 | ₹1,50,000 |
| 4 | Tab. Capecitabine 500mg | 3,000 | Nos | 15.44 | ₹46,320 |
| 5 | Inj.Carboplatin 150mg | 60 | Nos | 2,960 | ₹1,77,600 |
| 6 | Inj.Cisplatin 1mg/mL | 40 | Nos | 74 | ₹2,960 |
| 7 | Inj.Cyclophosphamide 500mg | 200 | Nos | 96 | ₹19,200 |
| 8 | Inj. Docetaxel 120mg | 50 | Nos | 744 | ₹37,200 |
| 9 | Inj.Doxorubicin 50mg | 200 | Nos | 672 | ₹1,34,400 |
| 10 | Tab. Gefitinib 250mg | 2,000 | Nos | 17.12 | ₹34,240 |
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 1.91 MB
BOQ_3843.xls
BOQ • 0.35 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .